These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1142 related articles for article (PubMed ID: 9422424)

  • 21. Blockade of CD40 ligand-CD40 interaction impairs CD4+ T cell-mediated alloreactivity by inhibiting mature donor T cell expansion and function after bone marrow transplantation.
    Blazar BR; Taylor PA; Panoskaltsis-Mortari A; Buhlman J; Xu J; Flavell RA; Korngold R; Noelle R; Vallera DA
    J Immunol; 1997 Jan; 158(1):29-39. PubMed ID: 8977172
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bone marrow-derived immature dendritic cells prime in vivo alloreactive T cells for interleukin-4-dependent rejection of major histocompatibility complex class II antigen-disparate cardiac allograft.
    Buonocore S; Flamand V; Goldman M; Braun MY
    Transplantation; 2003 Feb; 75(3):407-13. PubMed ID: 12589166
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Donor pretreatment with Flt-3 ligand augments antidonor cytotoxic T lymphocyte, natural killer, and lymphokine-activated killer cell activities within liver allografts and alters the pattern of intragraft apoptotic activity.
    Qian S; Lu L; Fu F; Li W; Pan F; Steptoe RJ; Chambers FG; Starzl TE; Fung JJ; Thomson AW
    Transplantation; 1998 Jun; 65(12):1590-8. PubMed ID: 9665075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD40-gp39 interactions play a critical role during allograft rejection. Suppression of allograft rejection by blockade of the CD40-gp39 pathway.
    Larsen CP; Alexander DZ; Hollenbaugh D; Elwood ET; Ritchie SC; Aruffo A; Hendrix R; Pearson TC
    Transplantation; 1996 Jan; 61(1):4-9. PubMed ID: 8560571
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-lymphocyte function-associated antigen-1 monoclonal antibody inhibits CD40 ligand-independent immune responses and prevents chronic vasculopathy in CD40 ligand-deficient mice.
    Corbascio M; Mahanty H; Osterholm C; Qi Z; Pearson TC; Larsen CP; Freise CE; Ekberg H
    Transplantation; 2002 Jul; 74(1):35-41. PubMed ID: 12134096
    [TBL] [Abstract][Full Text] [Related]  

  • 26. "Alternatively activated" dendritic cells preferentially secrete IL-10, expand Foxp3+CD4+ T cells, and induce long-term organ allograft survival in combination with CTLA4-Ig.
    Lan YY; Wang Z; Raimondi G; Wu W; Colvin BL; de Creus A; Thomson AW
    J Immunol; 2006 Nov; 177(9):5868-77. PubMed ID: 17056511
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prolongation of liver allograft survival by dendritic cells modified with NF-kappaB decoy oligodeoxynucleotides.
    Xu MQ; Suo YP; Gong JP; Zhang MM; Yan LN
    World J Gastroenterol; 2004 Aug; 10(16):2361-8. PubMed ID: 15285020
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Growth of donor-derived dendritic cells from the bone marrow of murine liver allograft recipients in response to granulocyte/macrophage colony-stimulating factor.
    Lu L; Rudert WA; Qian S; McCaslin D; Fu F; Rao AS; Trucco M; Fung JJ; Starzl TE; Thomson AW
    J Exp Med; 1995 Aug; 182(2):379-87. PubMed ID: 7629500
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-OX40L monoclonal antibody prolongs secondary heart allograft survival based on CD40/CD40L and LFA-1/ICAM-1 blockade.
    Dai H; Peng F; Lin M; Xia J; Yu S; Lan G; Wang Y; Xie X; Fang C; Corbascio M; Qi Z; Peng L
    Transpl Immunol; 2015 Mar; 32(2):84-91. PubMed ID: 25613092
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aggressive skin allograft rejection in CD28-/- mice independent of the CD40/CD40L costimulatory pathway.
    Ha J; Bingaman AW; Durham MM; Pearson TC; Larsen CP
    Transpl Immunol; 2001 Oct; 9(1):13-7. PubMed ID: 11680567
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Application of recipient-derived dendritic cells to induce donor-specific T-cell hyporesponsiveness.
    Tiao MM; Lu L; Tao R; Harnaha J; Fung JJ; Huang LT; Qian S
    Transplant Proc; 2004 Jun; 36(5):1592-4. PubMed ID: 15251391
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immature rat myeloid dendritic cells generated in low-dose granulocyte macrophage-colony stimulating factor prolong donor-specific rat cardiac allograft survival.
    DePaz HA; Oluwole OO; Adeyeri AO; Witkowski P; Jin MX; Hardy MA; Oluwole SF
    Transplantation; 2003 Feb; 75(4):521-8. PubMed ID: 12605121
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevention and restoration of second-set liver allograft rejection in presensitized mice: the role of "passenger" leukocytes, donor major histocompatibility complex antigens, and host cytotoxic effector mechanisms.
    Fu F; Li W; Lu L; Thomson AW; Fung JJ; Qian S
    Transplantation; 1999 Feb; 67(3):444-50. PubMed ID: 10030293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The influence of mycophenolate mofetil upon the maturation and allostimulatory activity of cultured dendritic cell progenitors and the effects of tolerance induction in allograft recipients].
    Han CH; Li HF; Wang YX; Zhang M; Wang Y; Yin M; Min ZL; Zheng KL
    Zhonghua Yi Xue Za Zhi; 2005 May; 85(19):1327-32. PubMed ID: 16029632
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survival in vivo.
    Lutz MB; Suri RM; Niimi M; Ogilvie AL; Kukutsch NA; Rössner S; Schuler G; Austyn JM
    Eur J Immunol; 2000 Jul; 30(7):1813-22. PubMed ID: 10940870
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microchimerism, donor dendritic cells, and alloimmune reactivity in recipients of Flt3 ligand-mobilized hemopoietic cells: modulation by tacrolimus.
    Morelli AE; Antonysamy MA; Takayama T; Hackstein H; Chen Z; Qian S; Zurowski NB; Thomson AW
    J Immunol; 2000 Jul; 165(1):226-37. PubMed ID: 10861056
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immature and mature CD8alpha+ dendritic cells prolong the survival of vascularized heart allografts.
    O'Connell PJ; Li W; Wang Z; Specht SM; Logar AJ; Thomson AW
    J Immunol; 2002 Jan; 168(1):143-54. PubMed ID: 11751957
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dendritic cells genetically engineered to express IL-4 exhibit enhanced IL-12p70 production in response to CD40 ligation and accelerate organ allograft rejection.
    Kaneko K; Wang Z; Kim SH; Morelli AE; Robbins PD; Thomson AW
    Gene Ther; 2003 Jan; 10(2):143-52. PubMed ID: 12571643
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systemic administration of anti-interleukin-10 antibody prolongs organ allograft survival in normal and presensitized recipients.
    Li W; Fu F; Lu L; Narula SK; Fung JJ; Thomson AW; Qian S
    Transplantation; 1998 Dec; 66(12):1587-96. PubMed ID: 9884244
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prolonged blockade of CD40-CD40 ligand interactions by gene transfer of CD40Ig results in long-term heart allograft survival and donor-specific hyporesponsiveness, but does not prevent chronic rejection.
    Guillot C; Guillonneau C; Mathieu P; Gerdes CA; Ménoret S; Braudeau C; Tesson L; Renaudin K; Castro MG; Löwenstein PR; Anegon I
    J Immunol; 2002 Feb; 168(4):1600-9. PubMed ID: 11823487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 58.